Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Protagonist Therapeutics Inc. | 2,449,183 | 2,449,183 | 0 | 213,912 | 258,144 | 39.57% | +44,232 |
| Nanobiotix S.A.(NBTX) | 5,623,816 | 5,623,816 | 0 | 130,023 | 173,607 | 26.61% | +43,585 |
| CVRx, Inc. | 4,024,861 | 4,024,861 | 0 | 28,577 | 38,075 | 5.84% | +9,499 |
| MeiraGTx Holdings plc(MGTX) | 6,641,064 | 6,641,064 | 0 | 52,796 | 57,512 | 8.82% | +4,715 |
| Contineum Therapeutics Inc. | 1,979,173 | 1,979,173 | 0 | 22,622 | 25,848 | 3.96% | +3,226 |
| Rapport Therapeutics, Inc.(RAPP) | 1,784,517 | 1,784,517 | 0 | 54,142 | 55,838 | 8.56% | +1,695 |
| Rallybio Corporation | 0 | 152,901 | +152,901 | 0 | 1,372 | 0.21% | +1,372 |
| Fate Therapeutics, Inc. | 3,379,064 | 3,379,064 | 0 | 3,320 | 4,055 | 0.62% | +735 |
| Neumora Therapeutics, Inc. | 1,849,445 | 1,849,445 | 0 | 3,311 | 3,606 | 0.55% | +296 |
| Vor Biopharma, Inc.(VOR) | 53,732 | 53,732 | 0 | 703 | 959 | 0.15% | +256 |
| Adicet Bio, Inc. | 22,779 | 22,779 | 0 | 192 | 155 | 0.02% | -37 |
| Standard BioTools, Inc. | 311,967 | 311,967 | 0 | 399 | 287 | 0.04% | -113 |
| Nano-X Imaging Ltd. ORD SHS | 158,852 | 83,554 | -75,298 | 445 | 190 | 0.03% | -255 |
| Lyell Immunopharma, Inc. | 54,887 | 0 | -54,887 | 1,689 | 0 | — | -1,689 |
| Procept BioRobotics Corporation(PRCT) | 357,939 | 357,939 | 0 | 11,261 | 8,952 | 1.37% | -2,309 |
| Xencor, Inc.(XNCR) | 748,062 | 748,062 | 0 | 11,453 | 9,022 | 1.38% | -2,431 |
| Rallybio Corporation | 3,636,363 | 0 | -3,636,363 | 2,495 | 0 | — | -2,495 |
| Legend Biotech Corporation(LEGN) | 814,586 | 814,586 | 0 | 17,709 | 14,736 | 2.26% | -2,973 |